Home | Sitemap | Contact Us | Login      
Loading
   

MPS Announcements, Articles & News alerts

Title: FIP 2003: Program of the Board of Pharmaceutical Practice
Date: 04-Mar-2003
Category: Affiliations

FIP 2003

Programme of the Board of Pharmaceutical Practice (BPP)
Saturday, 6 September 2003
09.00-17.00

Developing a new contract between Pharmacy and Society:
Risk management and improving outcomes

Introduction to the main theme:
Developing a new contract between Pharmacy and Society
At first sight, this congress theme appears a curious one. It acknowledges that future health care provision is expected to be patient-centered and quality driven. The idea was derived from an influential report from the Committee on the Quality of Health Care in America, which challenged the contemporary culture of health care provision and, in particular, focused on modernising the relationship between patients and health professionals in order to improve outcomes. The core contribution of pharmacy to its new contract would be:
Risk management and improving outcomes.

Pharmacists through their practice should be accountable for achieving these goals at both population and individual patient levels, and pharmaceutical services should be configured so that consumers can obtain the maximum benefits from their medicines at an affordable cost.

09.00-12.00

Symposium 1: A new health system for the 21st century: Crossing the quality chasm

Chairman: Peter Noyce, University of Manchester, UK
Co-chairman: John Bell, President of CPA, Australia
Introduction: Peter Noyce

  1. Introductory lecture on Crossing the Quality Chasm, Henri Manasse, USA 
  2. Response by a European speaker
    Peter Noyce,
    University of Manchester, UK
  3. Discussion by a designated Reactor Panel:
    Bente Frokjaer, Secretary of the Community Pharmacy Section, Denmark
    Philip Schneider, Secretary of the Hospital Pharmacy Section, Ohio, USA
    Han de Gier, President of the Pharmacy Information Section, Houten, The Netherlands
    Mei-Ling Hsiao, Centre for Drug Evaluation,Taipei, Taiwan

Discussion

By the end of this session the participants will be able to:

  • State six aims for the 21st century health care system
  • List ten rules for redesigning health care processes
  • Describe the impact on the Pharmacy profession of the publics concern regarding the quality of health care

14.00-17.00

Symposium 2: How does pharmacy add value: Reducing risks, improving outcomes
(Sponsored by an educational grant from IMS)

Chairman: TBA                                                                                                                                                                                       Co-chairman: Si Banks, Australia

The purpose of Symposium 2 is to consider within this new framework of healthcare delivery, how pharmacists can redesign their practice to improve the effectiveness and safety of the medicines they supply.

  1. Improving medicine related outcomes
    Speaker TBA
  2. Reducing the risks of medicines
    Inger Duus Nielsen, Danish Pharmaceutical Association,
    Copenhagen, Denmark
  3. Cost-effective use of medicines
    J.-Matthias Graf von der Schulenburg,
    University of Hannover, Germany
  4. Crucial contribution of pharmacists in shaping and implementing health care policies
    Per Troein, IMS Health Europe

Discussion

Case histories
  Australian perspective
  Speaker TBA
  European perspective
  Joe Asghar, UK

By the end of this session the participants will be able to:

  • State three strategies for pharmacy to improve medicine related outcomes
  • List three ways pharmacists can reduce the risks of medicines
  • Identify three methods by which the cost of medicines can be managed through pharmacy programmes


Sunday, 7 September 2003
09.00-12.00

Symposium 3: What does patient-centred practice mean for pharmacy?

Chairman: Lowell Anderson, American Pharmaceutical Association, MN, USA
Co-chairman: Jay Hooper, President of Pharmaceutical Society of Australia, Queensland Branch, Australia

Of course pharmacists interact with patients throughout their practice, but traditionally their relationship is paternalistic and asymmetrical, i.e. the pharmacist is in control . Pharmacists instruct/inform patients about the use of their medicines and provide medicines-related services which they believe will benefit their patients. This symposium is concerned with restructuring the relationship between patients and pharmacists and reconfiguring practices and service delivery from the perspective of the patient, i.e. is patient centred.

  1. Patient-centred drug therapy  Partnerships in medicine taking, Marja Airaksinen, University of Kuopio, Finland
  2. A patient focused approach  A pharmacy view, Charlie Benrimoj, University of Sydney, Australia
  3. A customer focused service  An airline view, Alastair Lindsay, Singapore Airlines Manager NSW & ACT, Sydney, Australia

Discussion

Case histories  Examples of patient-centred practice, Abilio de Almeida Neto, Pharmaceutical Society of Australia,                                           Grant Kardachi, President of the Pharmaceutical Society of Australia, South Australian Branch, Novar Gardens, Australia

By the end of this session the participants will be able to:

  • Describe the difference between a pharmacy-centred and patient-centred practice
  • List three examples of services that are associated with patient-centred pharmacy practice
  • Describe how the airline industry has created a customer centred business and how this applies to pharmacy


14.00-17.00

Symposium 4: Drug prescribers and pharmaceutical carers in integrated health care

Chairman: Jeff Poston, CEO, Canadian Pharmaceutical Association, Toronto, Canada
Co-chairman: John Bronger, President of the Pharmacy Guild of Australia, Canberra, Australia

Conventional pharmacy practice and education means that pharmacists learn or work either with other pharmacists or in
isolation (particularly in community pharmacy). With this new framework of care, the emphasis in Symposium 4 is to
remind pharmacists that:

  1. The drug-use process is both integrated and multi-disciplinary.
  2. That traditional roles are changing and becoming more inter-changeable,e.g. pharmacists and nurses taking responsibility for prescribing, and technicians taking responsibility for dispensing.
  3. These changes in practice require pharmacists to learn not in a uni-disciplinary environment, but together with other health professionals.
  1. IT in integrated health care  The pharmacy perspective, Lars Mortensen, CEO www.Sundhed.dk, Denmark
  2. Disease management protocols  A team approach, Dennis Helling, Kaiser Permanente, CO, USA
  3. Inter-professional education and training, John Smart, UK                                                                                                                                                                                                    Discussion
    Case histories of integrated health care  the Australian perspective, Speaker TBA
    By the end of this session the participants will be able to:
  • Define integrated health care as it relates to pharmacy practice
  • Describe how information technology can improve the integration of health care
  • Define disease management and how protocols can be used to integrate care and improve treatment outcome 
  • Describe how education and training programmes can create more integrated health care practices

Monday, 8 September 2003
09.00-12.00

Symposium 5: Public Accountability of the Pharmacy Profession

Chairman: Philip Schneider, College of Pharmacy, Ohio State University, USA
Co-chairman: Warwick Plunkett, President Pharmaceutical Society Australia, NSW Branch, Sydney, Australia

Within this new contract between Pharmacy and Society, the individual patients need to be informed of the practice standards and service performance they are guaranteed from pharmacies. In particular, patients should be reminded that the main purpose of pharmacists is to maximise the benefits and minimise the risks of medicines, as well as ensuring their efficient supply. Meanwhile, the general public needs to be assured that the pharmacy profession can be relied upon to be drug experts, and that transparent and robust systems are in place to ensure the competence-to-practice of all licensed/registered pharmacists.

  1. Practical accountability in the pharmacy. What the patient expects and what the pharmacist should offer, Speaker TBA 
  2. How do we learn from our mistakes? Quality control of health care and error reporting  Anonymous or identifiable? David Cousins, National Patient Agency, London, UK
  3. Public accountability  ethical and registration aspects. Control of the profession and lay involvement
    Philip Green, Royal Pharmaceutical Society of Great Britain,
    London, UK

Discussion
Case histories  Modernising the pharmacy profession, Francisco Guerreiro Gomes, Portugal, Maxine Goodman, Australia

By the end of this session the participants will be able to:

  • List five expectations that patients have from pharmacists
  • Discuss the balance of learning from error while maintaining public accountability
  • Describe how pharmacists are held responsible to the public for their services and the likelihood of this changing in the future

 



[ Back ] [ Print Friendly ]





Copyright © 2002 - 2017 Malaysian Pharmaceutical Society. All Rights Reserved.   Web Management

Powered by CORNERSTONE CONTENT MANAGEMENT SYSTEM